Deferasirox

( DrugBank: Deferasirox / KEGG DRUG: Deferasirox )


5 diseases
IDDisease name (Link within this page)Number of trials
54Adult still disease1
60Aplastic anemia1
254Porphyria2
IDDisease name (Link within this page)Number of trials
284Diamond-Blackfan anemia3
286Hereditary sideroblastic anemia4

54. Adult still disease


Clinical trials : 31 / Drugs : 39 - (DrugBank : 15) / Drug target genes : 12 - Drug target pathways : 116 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

60. Aplastic anemia


Clinical trials : 357 / Drugs : 477 - (DrugBank : 94) / Drug target genes : 57 - Drug target pathways : 184 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

254. Porphyria


Clinical trials : 85 / Drugs : 67 - (DrugBank : 18) / Drug target genes : 18 - Drug target pathways : 28 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

284. Diamond-Blackfan anemia


Clinical trials : 41 / Drugs : 123 - (DrugBank : 34) / Drug target genes : 24 - Drug target pathways : 125 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

286. Hereditary sideroblastic anemia


Clinical trials : 7 / Drugs : 27 - (DrugBank : 7) / Drug target genes : 8 - Drug target pathways : 40 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries